SPC-ATORVASTATIN DIN 02313723
Status: Marketed
Holder: SUN PHARMA CANADA INC
Molecule: ATORVASTATIN (ATORVASTATIN CALCIUM)
Available to quote
Health Canada record
| Active ingredient(s) | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AA05 ATORVASTATIN |
| Original market date | 20-May-2010 |
| Current status date | 13-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sun Pharma Canada Inc. — licence 3-002572, currently licensed, last inspection rating C (2026-06-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ATORVASTATIN (ATORVASTATIN CALCIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02348748 | ATORVASTATIN | SANIS HEALTH INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Marketed |
| 02348721 | ATORVASTATIN | SANIS HEALTH INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Marketed |
| 02348713 | ATORVASTATIN | SANIS HEALTH INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Marketed |
| 02348705 | ATORVASTATIN | SANIS HEALTH INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Marketed |
| 02230713 | LIPITOR | BGP PHARMA ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Marketed |
| 02243097 | LIPITOR | BGP PHARMA ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Marketed |
| 02230711 | LIPITOR | BGP PHARMA ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Marketed |
| 02230714 | LIPITOR | BGP PHARMA ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Marketed |
| 02333759 | PDP-ATORVASTATIN | PHARMASCIENCE INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Approved |
| 02333740 | PDP-ATORVASTATIN | PHARMASCIENCE INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Approved |
| 02333724 | PDP-ATORVASTATIN | PHARMASCIENCE INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Approved |
| 02333732 | PDP-ATORVASTATIN | PHARMASCIENCE INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Approved |
| 02324954 | SANDOZ ATORVASTATIN | SANDOZ CANADA INCORPORATED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Marketed |
| 02324970 | SANDOZ ATORVASTATIN | SANDOZ CANADA INCORPORATED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Marketed |
| 02324962 | SANDOZ ATORVASTATIN | SANDOZ CANADA INCORPORATED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Marketed |
| 02324946 | SANDOZ ATORVASTATIN | SANDOZ CANADA INCORPORATED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Marketed |
| 02313758 | SPC-ATORVASTATIN | SUN PHARMA CANADA INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Marketed |
| 02313715 | SPC-ATORVASTATIN | SUN PHARMA CANADA INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Marketed |
| 02313707 | SPC-ATORVASTATIN | SUN PHARMA CANADA INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Marketed |
| 02310910 | TEVA-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Marketed |
| 02310899 | TEVA-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Marketed |
| 02310902 | TEVA-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Marketed |
| 02310929 | TEVA-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Marketed |
| 02348659 | ATORVASTATIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Cancelled Post Market |
| 02348632 | ATORVASTATIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Cancelled Post Market |
| 02387891 | ATORVASTATIN | SIVEM PHARMACEUTICALS ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled Post Market |
| 02348624 | ATORVASTATIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled Post Market |
| 02348640 | ATORVASTATIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Cancelled Post Market |
| 02355612 | DOM-ATORVASTATIN | DOMINION PHARMACAL | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled Post Market |
| 02355647 | DOM-ATORVASTATIN | DOMINION PHARMACAL | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Cancelled Pre Market |
| 02355639 | DOM-ATORVASTATIN | DOMINION PHARMACAL | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Cancelled Post Market |
| 02355620 | DOM-ATORVASTATIN | DOMINION PHARMACAL | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Cancelled Post Market |
| 02288370 | GD-ATORVASTATIN | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Cancelled Post Market |
| 02288362 | GD-ATORVASTATIN | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Cancelled Post Market |
| 02288346 | GD-ATORVASTATIN | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled Post Market |
| 02288354 | GD-ATORVASTATIN | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Cancelled Post Market |
| 02373203 | MYLAN-ATORVASTATIN | MYLAN PHARMACEUTICALS ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled Post Market |
| 02373238 | MYLAN-ATORVASTATIN | MYLAN PHARMACEUTICALS ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Cancelled Post Market |
| 02373246 | MYLAN-ATORVASTATIN | MYLAN PHARMACEUTICALS ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Cancelled Post Market |
| 02373211 | MYLAN-ATORVASTATIN | MYLAN PHARMACEUTICALS ULC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Cancelled Post Market |
| 02302675 | NOVO-ATORVASTATIN | NOVOPHARM LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled Post Market |
| 02302683 | NOVO-ATORVASTATIN | NOVOPHARM LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Cancelled Post Market |
| 02302691 | NOVO-ATORVASTATIN | NOVOPHARM LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Cancelled Post Market |
| 02302713 | NOVO-ATORVASTATIN | NOVOPHARM LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Cancelled Post Market |
| 02384787 | NTP-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled Pre Market |
| 02384809 | NTP-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Cancelled Pre Market |
| 02384795 | NTP-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Cancelled Pre Market |
| 02384817 | NTP-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Cancelled Pre Market |
| 02313472 | PMS-ATORVASTATIN | PHARMASCIENCE INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Cancelled Post Market |
| 02313464 | PMS-ATORVASTATIN | PHARMASCIENCE INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Cancelled Post Market |
| 02313456 | PMS-ATORVASTATIN | PHARMASCIENCE INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Cancelled Post Market |
| 02313448 | PMS-ATORVASTATIN | PHARMASCIENCE INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled Post Market |
| 02376296 | Q-GEN ATORVASTATIN | Q-GEN PHARMACEUTICALS INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Cancelled (Unreturned Annual) |
| 02376318 | Q-GEN ATORVASTATIN | Q-GEN PHARMACEUTICALS INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Cancelled (Unreturned Annual) |
| 02376326 | Q-GEN ATORVASTATIN | Q-GEN PHARMACEUTICALS INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Cancelled (Unreturned Annual) |
| 02376288 | Q-GEN ATORVASTATIN | Q-GEN PHARMACEUTICALS INC | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled (Unreturned Annual) |
| 02350335 | RATIO-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 80 MG | Cancelled Post Market |
| 02350327 | RATIO-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG | Cancelled Post Market |
| 02350319 | RATIO-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 20 MG | Cancelled Post Market |
| 02350297 | RATIO-ATORVASTATIN | TEVA CANADA LIMITED | Tablet | ATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37897 | 2026-06-13 | Abbreviated New Drug Submission (ANDS) | Administrative: Merger/Buy-out. Administrative: Licensing Agreement between two manufacturers |
| 33176 | 2024-05-03 | Abbreviated New Drug Submission (ANDS) | Administrative: Change in Product Ownership |
| 23020 | 2019-12-13 | Abbreviated New Drug Submission (ANDS) | MANUFACTURER AND PRODUCT NAME CHANGE |
| 13558 | 2012-08-15 | Abbreviated New Drug Submission (ANDS) | Alternate formulation, manufacturing procedure and manufacturing site |
| 11393 | 2010-05-20 | New Drug Submission (NDS) | New manufacturer and product name |